Evaluation of Female Fertility-AMH and Ovarian Reserve Testing

被引:85
作者
Cedars, Marcelle, I [1 ]
机构
[1] Univ Calif San Francisco, Dept Obstet Gynecol & Reprod Sci, Div Reprod Endocrinol & Infertil, San Francisco, CA 94143 USA
关键词
AMH; ovarian reserve; female infertility; ANTI-MULLERIAN HORMONE; ANTRAL FOLLICLE COUNT; IN-VITRO FERTILIZATION; MENSTRUAL-CYCLE LENGTH; POSEIDON GROUPS 3; ANTIMULLERIAN HORMONE; MANAGEMENT STRATEGIES; STIMULATING-HORMONE; OVULATION INDUCTION; ROTTERDAM CRITERIA;
D O I
10.1210/clinem/dgac039
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Context Evaluation of the infertile female requires an understanding of ovulation and biomarkers of ovarian reserve. Antimullerian hormone (AMH) correlates with growing follicles in a menstrual cycle. Increasingly, AMH has been used as a "fertility test." This narrative review describes how to integrate the use of AMH into diagnosis and treatment. Methods A PubMed search was conducted to find recent literature on measurements and use of serum AMH as a marker of ovarian reserve and in treatment of infertility. Results Serum AMH estimates ovarian reserve, helps determine dosing in ovarian stimulation, and predicts stimulation response. As such, AMH is a good marker of oocyte quantity but does not reflect oocyte health or chances for pregnancy. Screening of AMH before fertility treatment should be used to estimate expected response and not to withhold treatment. Low AMH levels may suggest a shortened reproductive window. AMH levels must be interpreted in the context of the endogenous endocrine environment where low follicle-stimulating hormone, due to hypogonadotropic hypogonadism or hormonal contraceptive use, may lower AMH without being a true reflection of ovarian reserve. In addition, there is an inverse correlation between body mass index and AMH that does not reflect ovarian response. Conclusion AMH is a useful marker of ovarian reserve in reproductive-aged women. Increased screening of noninfertile women requires a thorough knowledge of situations that may affect AMH levels. In no situation does AMH reflect oocyte health or chances for conception. Age is still the strongest driver in determining success rates with fertility treatments.
引用
收藏
页码:1510 / 1519
页数:10
相关论文
共 90 条
[1]   A randomized controlled trial investigating the use of a predictive nomogram for the selection of the FSH starting dose in IVF/ICSI cycles [J].
Allegra, Adolfo ;
Marino, Angelo ;
Volpes, Aldo ;
Coffaro, Francesco ;
Scaglione, Piero ;
Gullo, Salvatore ;
La Marca, Antonio .
REPRODUCTIVE BIOMEDICINE ONLINE, 2017, 34 (04) :429-438
[2]   Disposition of abandoned embryos: a committee opinion [J].
Amato, Paula ;
Brzyski, Robert ;
Braverman, Andrea ;
Benward, Jean ;
Stein, Andrea ;
Lamb, Dolores ;
Steinbock, Bonnie ;
Wilder, Bruce ;
Reindollar, Richard ;
Francis, Leslie ;
Robertson, John ;
Daar, Judith ;
Fisseha, Senait ;
Ralston, Steven ;
Sauer, Mark ;
Spillman, Monique ;
Rebar, Robert ;
Tipton, Sean .
FERTILITY AND STERILITY, 2013, 99 (07) :1848-1849
[3]   Assessment of Circulating Anti-Mullerian Hormone in Women Using Hormonal Contraception: A Systematic Review [J].
Amer, Saad A. K. S. ;
James, Cathryn ;
Al-Hussaini, Tarek Khalf ;
Mohamed, Ahmed Aboelfadle .
JOURNAL OF WOMENS HEALTH, 2020, 29 (01) :100-110
[4]   Optimizing natural fertility: a committee opinion [J].
Pfeifer S. ;
Butts S. ;
Fossum G. ;
Gracia C. ;
La Barbera A. ;
Mersereau J. ;
Odem R. ;
Paulson R. ;
Penzias A. ;
Pisarska M. ;
Rebar R. ;
Reindollar R. ;
Rosen M. ;
Sandlow J. ;
Vernon M. .
FERTILITY AND STERILITY, 2017, 107 (01) :52-58
[5]   Diagnosis of polycystic ovarian syndrome: The Rotterdam criteria are premature [J].
Azziz, R .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2006, 91 (03) :781-785
[6]   The management of anovulatory infertility in women with polycystic ovary syndrome: an analysis of the evidence to support the development of global WHO guidance [J].
Balen, Adam H. ;
Morley, Lara C. ;
Misso, Marie ;
Franks, Stephen ;
Legro, Richard S. ;
Wijeyaratne, Chandrika N. ;
Stener-Victorin, Elisabet ;
Fauser, Bart C. J. M. ;
Norman, Robert J. ;
Teede, Helena .
HUMAN REPRODUCTION UPDATE, 2016, 22 (06) :687-708
[7]   Maternal menopause as a predictor of anti-Mullerian hormone level and antral follicle count in daughters during reproductive age [J].
Bentzen, J. G. ;
Forman, J. L. ;
Larsen, E. C. ;
Pinborg, A. ;
Johannsen, T. H. ;
Schmidt, L. ;
Friis-Hansen, L. ;
Andersen, A. Nyboe .
HUMAN REPRODUCTION, 2013, 28 (01) :247-255
[8]   Duration, recency, and type of hormonal contraceptive use and antimullerian hormone levels [J].
Bernardi, Lia A. ;
Weiss, Marissa Steinberg ;
Waldo, Anne ;
Harmon, Quaker ;
Carnethon, Mercedes R. ;
Baird, Donna D. ;
Wise, Lauren A. ;
Marsh, Erica E. .
FERTILITY AND STERILITY, 2021, 116 (01) :208-217
[9]   Genetics of premature ovarian failure [J].
Bilgin, Ekrem M. ;
Kovanci, Ertug .
CURRENT OPINION IN OBSTETRICS & GYNECOLOGY, 2015, 27 (03) :167-174
[10]   Use of in-cycle antimullerian hormone levels to predict cycle outcome [J].
Blazar, Andrew S. ;
Lambert-Messerlian, Geralyn ;
Hackett, Richard ;
Krotz, Stephan ;
Carson, Sandra A. ;
Robins, Jared C. .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2011, 205 (03) :223.e1-223.e5